Safety and Efficacy of Skincare Products for Managing Mild to Moderate Acne in Individuals With Sensitive Skin
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: Cleanser, Toner, Serum, Day cream.
- Кому может быть актуально
- Состояния в реестре: Acne. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Малайзия
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Обзор
To investigate the safety and efficacy of a skincare regimen in individuals with mild to moderate acne and sensitive skin. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4. The main questions this study aims to answer are: 1. To investigate the safety of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin. 2. To determine the efficacy of the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin. 3. To assess the participants' satisfaction with the skincare regimen products in managing mild to moderate acne in individuals with sensitive skin.
Вмешательства
- Другое Cleanser
Each participant will be provided with a Gentle deep cleanser, 100 mL containing Cocos Nucifera (Coconut) Oil, to be applied for 4 weeks according to the specified instructions. - Другое Toner
Each participant will be provided with a Dewy cheeks revitalising toner, 100 mL containing Cocos Nucifera (Coconut) Oil, to be applied for 4 weeks according to the specified instructions. - Другое Serum
Each participant will be provided with a Deep serum, 30 mL containing Cocos Nucifera (Coconut) Oil, to be applied for 4 weeks according to the specified instructions. - Другое Day cream
Each participant will be provided with a moisturizing day cream, 50 gm containing Cocos Nucifera (Coconut) Oil, to be applied for 4 weeks according to the specified instructions. - Другое Night cream
Each participant will be provided with a moisturizing night cream, 50 gm containing Cocos Nucifera (Coconut) Oil, to be applied for 4 weeks according to the specified instructions.
Первичные конечные точки
- Comprehensive Acne Severity Scale Classification (CASS) [Срок оценки: baseline, week 4]
- Acne lesion counts [Срок оценки: baseline, week 4]
Вторичные конечные точки (2)
- Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability] [Срок оценки: 4 weeks]
- Participant satisfaction [Срок оценки: week 4]
Критерии участия
Критерии включения
- Healthy Malaysian women and men
- Fitzpatrick skin type II-V
- Age above 18 years old
- Individuals with sensitive skin identify through sensitive skin survey (Corazza et al., 2022) and lactic acid sting test (LAST).
- Individuals with mild to moderate acne, based on Comprehensive Acne Severity Scale (CASS)
Критерии исключения
- Pregnant or breastfeeding women, or those planning pregnancy during the study period.
- Individuals with documented autoimmune diseases or other conditions that may affect immune response or skin barrier function.
- Individuals with a history of severe skin sensitivity reactions, including frequent intense erythema, swelling, or intolerable burning in response to topical products.
- Individuals with severe acne requiring medical treatment or systemic treatment such as nodulocystic acne.
- Individuals with active inflammatory or allergic dermatological conditions affecting the face, such as atopic dermatitis, eczema, or psoriasis, which may compromise skin barrier function or interfere with study assessments.
- Individuals who have undergone cosmetic or dermatological procedures such as -chemical peel, microneedling, or any procedures aimed at improving acne, within 3 months prior to the study.
- Individuals currently taking medical or hormonal treatments that may interfere with study outcomes, including anti-inflammatory agents, corticosteroids, or other medication interfering with study objectives.
- Individuals with known allergy or hypersensitivity to any ingredients found in the product.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Распределение
- Не применимо
- Модель
- Одна группа
- Маскирование
- Открытое
- Основная цель
- Поддерживающая терапия
Центры проведения
Малайзия · 1 центр
- USMARI Research & Innovation Centre — Petaling Jaya
Идентификаторы
NCT: NCT07749469 · USMR-26-1